NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Genre Technical Report Remove constraint Genre: Technical Report

Search Results

301. Anthrax: developing drugs for prophylaxis of inhalational anthrax

303. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report

304. Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report

305. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases

307. Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

309. Antibiotic resistance: more information needed to oversee use of medically important drugs in food animals : report to Congressional requesters

310. Antibiotic stewardship in hospitals and long-term care facilities: building an effective program

311. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters

313. Anticoagulation management service: safer care, maximizing outcomes

315. Antimicrobial therapy for pneumonia in Pennsylvania long-term care: a spotlight on culture

316. Antipsychotic medication prescribing in long-term care facilities increased in the early months of the COVID-19 pandemic

317. Antithrombotics: indications and management : a national clinical guideline

319. Appeal options available to mammography facilities concerning adverse accreditation decisions, suspension/revocation of certificates, or patient and physician notification orders: guidance for mammography facilities and Food and Drug Administration staff

326. Approaches to making practice and system changes to improve patient and family engagement: 12 ways hospitals integrate family caregiver support

327. Appropriate use of voluntary consensus standards in premarket submissions for medical devices: guidance for industry and Food and Drug Administration staff

330. Are Medicare patients getting sicker?

331. Are age-62/63 retired worker beneficiaries at risk?

333. Are many retirees with dementia lacking help?

334. Are older men healthy enough to work?

338. Are premium subsidies available in states with a federally-run marketplace?: a guide to the Supreme Court argument in King v. Burwell

339. Are there "hot spots" of primary impairments among new SSDI awardees--and do we know why?

342. Are you ready to respond?: reports of high harm complications after surgery and invasive procedures

345. Arthroscopy pump tubing sets intended for multiple patient use - Premarket Notification (510(k)) submissions: guidance for industry and Food and Drug Administration staff

346. Artificial intelligence in health care: benefits and challenges of machine learning technologies for medical diagnostics : report to congressional requesters

347. As funding for BPA research increased, NIEHS followed its peer review process while also exercising its discretion

348. As it grows, Medicare Advantage is enrolling more low-income and medically complex beneficiaries: recent trends in beneficiary clinical characteristics, health care utilization, and spending

349. Assessing 'first visits' by physicians to Medicare patients discharged to skilled nursing facilities

350. Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment

352. Assessing and addressing legal barriers to the clinical integration of community health centers and other community providers

353. Assessing health care access among Medicaid/CHIP-enrolled children in Illinois: changes in policy and practice to improve access

354. Assessing health care access among Medicaid/CHIP-enrolled children: a national chartbook, 2016–19

357. Assessing the California Children's Services Program

358. Assessing the access and equity concerns in a Medicare-X-style public option reform

360. Assessing the effectiveness of policies to improve access to primary care for underserved populations. Case study analysis of Columbia County, Arkansas

361. Assessing the effectiveness of policies to improve access to primary care for underserved populations: case study analysis : Grant County, New Mexico

362. Assessing the effectiveness of policies to improve access to primary care for underserved populations: case study analysis : Kanawha County, West Virginia

363. Assessing the effectiveness of policies to improve access to primary care for underserved populations: case study analysis. Baltimore City, Maryland

364. Assessing the effectiveness of policies to improve access to primary care for underserved populations: case study analysis. Detroit, Michigan

366. Assessing the impact of California's nurse staffing ratios on hospitals and patient care

367. Assessing the potential impact of sequestration in community health centers, patients, and medically underserved communities

368. Assessing the potential impact of state policies on community health centers' outreach and enrollment activities

369. Assessing the potential impact of the Affordable Care Act on uninsured community health center patients: a nationwide and state-by-state analysis

370. Assessing the potential impact of the Affordable Care Act on uninsured community health center patients: an update

371. Assessing the usability of MAX 2008 encounter data for enrollees in comprehensive managed care

372. Assessing the usability of encounter data for enrollees in comprehensive managed care 2010-2011

374. Assessing the usability of the MAX 2007 inpatient and prescription encounter data for enrollees in comprehensive managed care

377. Assessing user fees under the Prescription Drug User Fee Amendments of 2017

378. Assessing user fees under the biosimilar user fee amendments of 2017

381. Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states

382. Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults, children and young people, which may indicate a higher risk of progression to severe disease : evidence review

385. Assessment of the literature on integrated care models for people dually enrolled in Medicare and Medicaid: approaches used and priorities for future research

386. Assessment tools help diagnose obstructive sleep apnea

389. The asset and income profile of residents in seniors care communities

390. Assisted living and residential care in the states in 2010

392. Association between electronic medical record implementation of default opioid prescription quantities and prescribing behavior in two emergency departments

393. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

394. Association of rideshare-based transportation services and missed primary care appointments: a clinical trial

395. Associations between county-level vaccination rates and COVID-19 outcomes among Medicare beneficiaries

396. Associations between county-level vaccination rates and COVID-19 outcomes among Medicare beneficiaries

397. Automatically enrolling eligible children and families into Medicaid and SCHIP: opportunities, obstacles, and options for federal policymakers

398. The availability and usability of behavioral health organization encounter data in MAX 2009

399. Availability and use of enrollment data from the ACA health insurance marketplace